Healthcare - Biotechnology - NASDAQ - US
$ 5.53
4.34 %
$ 291 M
Market Cap
-1.52
P/E
INCOME STATEMENT
0
REVENUE
-277 M
OPERATING INCOME
-260 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Kodiak Sciences Inc.
| Revenue | 0 |
| Cost Of Revenue | 25.9 M |
| Gross Profit | -25.9 M |
| Operating Expenses | 277 M |
| Operating Income | -277 M |
| Other Expenses | -16.8 M |
| Net Income | -260 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 25.9 | 11.0 | 8.7 | 4.2 | 0.9 | 0.5 | 0.5 | 0.3 |
| Gross Profit | (25.9) | (11.0) | (8.7) | (4.2) | (0.9) | (0.5) | (0.5) | (0.3) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 277.3 | 341.4 | 267.1 | 136.0 | 49.2 | 26.4 | 25.5 | 17.2 |
| Selling, General and Administrative Expenses | 71.0 | 73.8 | 49.7 | 28.6 | 11.7 | 7.6 | 3.5 | 3.1 |
| Research and Development Expenses | 206.3 | 267.6 | 217.3 | 107.4 | 37.5 | 18.8 | 22.0 | 14.1 |
| Operating Income | (277.3) | (341.4) | (267.1) | (136.0) | (49.2) | (26.4) | (25.5) | (17.2) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 13 K | 18 K | 22 K | 25 K | 8 K | 5.5 | 1.2 | 6 K |
| Total Other Income | 16.8 | 7.6 | 61 K | 2.9 | 1.8 | (15.1) | (2.4) | 19 K |
| Pre-Tax Income | (260.5) | (333.8) | (267.0) | (133.1) | (47.4) | (41.4) | (27.9) | (17.1) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 7.3 | (0.2) | 2.7 | (0.6) | (9.6) | 45 K | 31 K |
| Net Income | (260.5) | (333.8) | (267.0) | (133.1) | (46.7) | (41.4) | (27.9) | (17.1) |
| EPS | 4.97 | 6.39 | 5.16 | 2.91 | 1.23 | 2.77 | 1.05 | 0.65 |